• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 Phoenix Study.

作者信息

Călugăru Dan, Călugăru Mihai

机构信息

Cluj-Napoca, Romania.

出版信息

Am J Ophthalmol. 2019 Feb;198:262-263. doi: 10.1016/j.ajo.2018.09.027. Epub 2018 Nov 3.

DOI:10.1016/j.ajo.2018.09.027
PMID:30401482
Abstract
摘要

相似文献

1
Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 Phoenix Study.康柏西普治疗新生血管性年龄相关性黄斑变性：3期随机凤凰研究结果
Am J Ophthalmol. 2019 Feb;198:262-263. doi: 10.1016/j.ajo.2018.09.027. Epub 2018 Nov 3.
2
Comment on: Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study.评论：康柏西普治疗新生血管性年龄相关性黄斑变性：随机3期PHOENIX研究结果
Am J Ophthalmol. 2020 Jan;209:216. doi: 10.1016/j.ajo.2019.07.026. Epub 2019 Nov 4.
3
Reply to Comment on: Conbercept for Treatment of Neovascular Age-Related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study.
Am J Ophthalmol. 2020 Jul;215:154-155. doi: 10.1016/j.ajo.2019.12.007. Epub 2020 Mar 16.
4
Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.康柏西普（KH-902）用于治疗新生血管性年龄相关性黄斑变性。
Expert Rev Clin Pharmacol. 2015;8(5):541-8. doi: 10.1586/17512433.2015.1075879. Epub 2015 Aug 10.
5
One-Year Outcomes of Intravitreal Conbercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration.玻璃体内注射康柏西普治疗难治性新生血管性年龄相关性黄斑变性的一年结局
Ophthalmic Res. 2019;62(2):93-100. doi: 10.1159/000500118. Epub 2019 May 23.
6
Profile of conbercept in the treatment of neovascular age-related macular degeneration.康柏西普治疗新生血管性年龄相关性黄斑变性的概况
Drug Des Devel Ther. 2015 Apr 22;9:2311-20. doi: 10.2147/DDDT.S67536. eCollection 2015.
7
SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR BEFORE AND AFTER INTRAVITREAL INJECTION OF RANIBIZUMAB OR CONBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.玻璃体内注射雷珠单抗或康柏西普治疗新生血管性年龄相关性黄斑变性前后的血清血管内皮生长因子水平
Retina. 2017 May;37(5):971-977. doi: 10.1097/IAE.0000000000001274.
8
Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study.康柏西普治疗新生血管性年龄相关性黄斑变性的安全性和有效性：一项为期 12 个月的随机 2 期研究结果：AURORA 研究。
Ophthalmology. 2014 Sep;121(9):1740-7. doi: 10.1016/j.ophtha.2014.03.026. Epub 2014 May 1.
9
Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept.玻璃体内注射治疗新生血管性年龄相关性黄斑变性后脉络膜厚度的变化：雷珠单抗与阿柏西普对比
J Fr Ophtalmol. 2017 Dec;40(10):832-838. doi: 10.1016/j.jfo.2017.04.014. Epub 2017 Nov 5.
10
Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration.在治疗新生血管性年龄相关性黄斑变性时，在雷珠单抗和阿柏西普之间转换。
Surv Ophthalmol. 2018 Sep-Oct;63(5):638-645. doi: 10.1016/j.survophthal.2018.02.004. Epub 2018 Feb 22.

引用本文的文献

1
Quantitative characterization of types 1 and 2 macular neovascularization in neovascular age-related macular degeneration with intravitreal conbercept: an analysis utilizing optical coherence tomography angiography.玻璃体内注射康柏西普治疗新生血管性年龄相关性黄斑变性中1型和2型黄斑新生血管的定量特征：一项利用光学相干断层扫描血管造影的分析
Int J Ophthalmol. 2025 Aug 18;18(8):1490-1497. doi: 10.18240/ijo.2025.08.10. eCollection 2025.
2
Clinical efficacy and changes of serum VEGF-A, VEGF-B, and PLGF after conbercept treating neovascular age-related macular degeneration.康柏西普治疗新生血管性年龄相关性黄斑变性后的临床疗效及血清血管内皮生长因子A、血管内皮生长因子B和胎盘生长因子的变化
Int J Ophthalmol. 2023 Sep 18;16(9):1489-1495. doi: 10.18240/ijo.2023.09.16. eCollection 2023.
3
Comment on: Real-world outcomes of two-year Conbercept therapy for diabetic macular edema.关于《康柏西普治疗糖尿病性黄斑水肿两年的真实世界研究结果》的评论
Int J Ophthalmol. 2022 Apr 18;15(4):681-682. doi: 10.18240/ijo.2022.04.27. eCollection 2022.
4
Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies.再探年龄相关性黄斑变性：从病理与细胞应激到潜在疗法
Front Cell Dev Biol. 2021 Jan 25;8:612812. doi: 10.3389/fcell.2020.612812. eCollection 2020.
5
Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020.2020 年治疗新生血管性年龄相关性黄斑变性的新方法。
Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):250-259. doi: 10.1097/APO.0000000000000291.
6
Romanian ophthalmologists in the renowned ophthalmic journals worldwide.罗马尼亚眼科医生发表于全球知名眼科期刊上的文章。 （原英文表述不太完整准确，推测完整意思应该是类似这样，若按照字面翻译是：罗马尼亚眼科医生在全球著名眼科期刊里）
Rom J Ophthalmol. 2018 Oct-Dec;62(4):260-269.